Clinical Trial Update: Clinical Trial Comparing Gemcitabine and Vandetanib Therapy With Gemcitabine Alone in Pancreatic Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial comparing gemcitabine alone versus gemcitabine plus vandetanib in pancreatic cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Gemcitabine (Gemcitabine)
• Vandetanib (vandetanib)

Snippet

Sponsor: University of Liverpool | Conditions: Pancreatic Cancer | Phase 2 | Status: COMPLETED